Experts Say GLP-1 Drugs Have Potential Use Beyond Weight Loss
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s [...]
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance
The health care giant’s David Ricks defended the agency’s role [...]
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain [...]
Eli Lilly’s Popular Weight Loss Drug, Zepbound, Is Getting a Price Cut
Eli Lilly will now sell cheaper vials of Zepbound, presenting [...]
U.S. Unveils Price Limits for 10 Costly or Common Medications
The Biden administration said it would have saved $6 billion [...]
U.S. Announces Prices for First Drugs Picked for Medicare Negotiations
The Biden administration said it would have saved $6 billion [...]
Ozempic y otros medicamentos para adelgazar: ¿Cuál elegir?
Mientras los pacientes se plantean fármacos como Wegovy, Ozempic, Zepbound [...]
Ozempic and Weight Loss Drugs: Which Should You Choose?
As patients consider drugs like Wegovy, Ozempic, Zepbound and Mounjaro [...]
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]
Algunos estados en EE. UU. afirman que no pueden costear Ozempic y otros medicamentos para perder peso
Los empleados públicos de Virginia Occidental que tomaron los fármacos [...]